Benzoylecgonine

Detecting cocaine use in federally mandated SAMHSA and DOT workplace drug testing programs, forensic toxicology investigations, clinical toxicology screening, pain management compliance monitoring, criminal justice testing, and substance abuse treatment programs relies on benzoylecgonine, the primary urinary metabolite of cocaine. UTAK’s drugs of abuse panels contain benzoylecgonine in urine matrix at multiple concentration levels, supporting both immunoassay screening and GC-MS or LC-MS/MS confirmatory methods required by federal and non-regulated testing guidelines. Stock and custom QC solutions can incorporate the parent compound cocaine along with other commonly tested drugs of abuse such as THC, phencyclidine, amphetamines, and opiates to support comprehensive controlled substance QC programs.